Effect of Meditation as an Adjunct to Cardiac Rehabilitation

NCT07310992 · tracked via the Priya Life Science Brazil tracker

Sponsor

Instituto Dante Pazzanese de Cardiologia

Phase

Not applicable

Started

2026-03-03

Last updated

2026-08-26

Condition(s) studied

High Blood Pressure (& [Essential Hypertension])Meditation TrainingRehabilitation Exercise

Investigational drug(s) / intervention(s)

MeditationStandard Cardiac Rehabilitation

Meditation: Participants in this group will undergo the standard cardiac rehabilitation program consisting of 60 minutes of aerobic and resistance training, twice a week for 12 weeks. Additionally, they will participate in a 15-minute voice-guided mindfulness meditation session immediately following each exercise session. Participants also receive optimized medical therapy.

Standard Cardiac Rehabilitation: Participants in this group will undergo the standard cardiac rehabilitation program consisting of 60 minutes of aerobic and resistance training, twice a week for 12 weeks, along with optimized medical therapy. This group does not receive the guided meditation intervention.

Study summary

Cardiovascular rehabilitation is a well-established standard of care that significantly reduces morbidity and mortality while improving quality of life. However, integrating behavioral interventions into physical training may offer additional benefits for autonomic regulation and emotional well-being.

This randomized clinical trial aims to investigate the efficacy of adding a brief, guided mindfulness meditation session to a standard cardiovascular rehabilitation program. The study seeks to determine whether this combined intervention enhances blood pressure control, improves perceived quality of life, and increases patient adherence compared to standard rehabilitation alone.

Participants newly enrolled in the Cardiac Rehabilitation Service will be randomized into two groups. Both groups will undergo a standard 12-week regimen of aerobic and resistance training combined with optimized medical therapy. The intervention group will additionally receive 15 minutes of voice-guided mindfulness meditation at the end of each exercise session. Key outcome measures include blood pressure variability, quality of life scores (assessed via EQ-5D), and attendance rates.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients of both sexes, aged 18 years or older. * Newly enrolled in the Phase II Cardiac Rehabilitation Program. * Clinically stable condition with medical clearance to perform aerobic and resistance exercises. * Diagnosis of cardiovascular disease (e.g., coronary artery disease, post-myocardial infarction, post-cardiac surgery, or stable heart failure) warranting rehabilitation. * Willingness and cognitive ability to provide written informed consent. * Availability to attend the twice-weekly sessions for the 12-week duration of the study. Exclusion Criteria: * Current regular practice of meditation, yoga, or other mind-body techniques (defined as formal practice more than once a week in the previous 3 months). * Current participation in other psychological or behavioral intervention clinical trials. * Severe cognitive impairment or psychiatric disorders that preclude understanding of the meditation instructions or group participation (e.g., dementia, untreated psychosis). * Unstable clinical conditions such as unstable angina, uncontrolled arrhythmias, or decompensated heart failure that contraindicate physical exercise. * Significant orthopedic or neurological limitations that prevent the performance of the exercise protocol. * Refusal to participate in the randomization process.

Primary outcome measure(s)

Quality of Life Scores (EuroQol EQ-5D Visual Analogue Scale) — Baseline and Week 12
Quality of life is assessed using the EuroQol Five Dimensions Questionnaire (EQ-5D). This instrument includes the EQ Visual Analogue Scale (EQ-VAS), a quantitative measure of the participant's self-rated health status. The EQ-VAS scores range from a minimum of 0 to a maximum of 100, where 0 represents 'the worst health you can imagine' and 100 represents 'the best health you can imagine'. Higher scores indicate better health outcomes and higher quality of life.

Trial sites (1)

Facility	City	Region	Status
Instituto Dante Pazzanese de Cardiologia	São Paulo	São Paulo	Recruiting

More Instituto Dante Pazzanese de Cardiologia trials in Brazil

Rapid Management of Resistant Hypertension in the Public Health System (Fast Control) Recruiting

Valvular Assessment of New Generation Aortic Replacement Devices Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07310992 on ClinicalTrials.gov ↗ ← All trials in Brazil